FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Reinhard Buettner

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Anatomy

Disorders

Concepts & Ideas

Molecular Sequence Data

Procedures

Physiology

Gene Expression Regulation, Neoplastic

Co-author Network

Publications

TOP 3
Reinhard Buettner; Jürgen Wolf; Roman K Thomas
Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment.
Katharina König; Cornelia Kröger; Thomas M Magin; Lydia Meder; Ursula Rommerscheidt-Fuss; Eva Wardelmann; Reinhard Buettner; Linda Diehl; Alexandra Florin; Philip Kahl; Lukas Heukamp
Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model.
Christoph Engel; Encarna Gómez García; Timm O Goecke; Heike Goergens; Frederik J Hes; Elke Holinski-Feder; Nicoline Hoogerbrugge; Irma Kluijt; Tom G W Letteboer; Markus Loeffler; Fred H Menko; Gabriela Moeslein; Peter Propping; Nils Rahner; Hans K Schackert; Wolff Schmiegel; Rolf H Sijmons; Verena Steinke; Theo A M van Os; Reinhard Buettner; Wolfgang Dietmaier; Magnus von Knebel Doeberitz; Anja Wagner; Hans F A Vasen
Risks of less common cancers in proven mutation carriers with lynch syndrome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Reinhard Buettner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Reinhard Buettner; Jürgen Wolf; Roman K Thomas
Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(15):1858-65.
2013: Katharina König; Cornelia Kröger; Thomas M Magin; Lydia Meder; Ursula Rommerscheidt-Fuss; Eva Wardelmann; Reinhard Buettner; Linda Diehl; Alexandra Florin; Philip Kahl; Lukas Heukamp
Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model.
PloS one 2013;8(3):e57996.
2012: Christoph Engel; Encarna Gómez García; Timm O Goecke; Heike Goergens; Frederik J Hes; Elke Holinski-Feder; Nicoline Hoogerbrugge; Irma Kluijt; Tom G W Letteboer; Markus Loeffler; Fred H Menko; Gabriela Moeslein; Peter Propping; Nils Rahner; Hans K Schackert; Wolff Schmiegel; Rolf H Sijmons; Verena Steinke; Theo A M van Os; Reinhard Buettner; Wolfgang Dietmaier; Magnus von Knebel Doeberitz; Anja Wagner; Hans F A Vasen
Risks of less common cancers in proven mutation carriers with lynch syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4409-15.
2012: Dominica Willmann; Ignasi Forné; Axel imhof; Anett Jandausch; Andreas Janzer; Manfred Jung; Jutta Kirfel; Soyoung Lim; Eric Metzger; Roland Schüle; Herbert Waldmann; Stefan Wetzel; Wolfram Wilk; Reinhard Buettner
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
International journal of cancer. Journal international du cancer 2012;131(11):2704-9.
2012: Hans-Ulrich Schildhaus; Andreas Schlesinger; Katja Schmitz; Roland Schnell; Wolfgang Schulte; Monika Serke; Martin Sos; Erich Stoelben; Jürgen Wolf; Thomas Zander; Walburga Engel-Riedel; Konrad F Frank; Ulrich Gerigk; Friederike Göke; Khosro Hekmat; Lukas Heukamp; Sebastian Huss; Yon-Dschun Ko; Christian Mattonet; Sabine Merkelbach-Bruse; Ellen Paggen; Sven Perner; Marcel Reiser; Katharina Riesner; Kerstin Albus; Sascha Ansén; Elke Binot; Marc Bos; Michael Brockmann; Reinhard Buettner
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(11):1473-80.
2012: Andreas Janzer; Astrid Becker; Reinhard Buettner; Katrin Stamm; Andreas Zimmer; Jutta Kirfel
The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
The Journal of biological chemistry 2012;287(37):30984-92.
2012: Andreas Janzer; Reinhard Buettner; Florian Fronhoffs; Soyoung Lim; Naima Niazy; Jutta Kirfel
Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components.
Biochemical and biophysical research communications 2012;421(4):665-70.
2012: Zaki Shaikhibrahim; Reinhard Buettner; Jörg Ellinger; Andreas Lindstrot; Sven Perner; Sebastian Rogenhofer; Nicolas Wernert
The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?
Molecular medicine reports 2012;5(2):313-6.
2012: Nuran Serce; Susanne Steiner; Annette Gnatzy; Jutta Kirfel; Henning Lorenzen; Reinhard Buettner
Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast.
BMC clinical pathology 2012;12():13.
2012: Zaki Shaikhibrahim; Reinhard Buettner; Jörg Ellinger; Andreas Lindstrot; Sebastian Rogenhofer; Nicolas Wernert
Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors.
Molecular medicine reports 2012;5(1):32-6.
2011: Lucia Gullotti; Philip Kahl; Jutta Kirfel; Peter Propping; Nils Rahner; Roland Schüle; Verena Steinke; Reinhard Buettner; Jacqueline Czerwitzki; Christoph Engel; Nicolaus Friedrichs
FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer.
Laboratory investigation; a journal of technical methods and pathology 2011;91(12):1695-705.
2011: Hagen S Bachmann; Reinhard Buettner; Angelika Eggert; Andreas Eisenhardt; Lukas Heukamp; Caroline F Hilburn; Philip Kahl; Holger Nückel; Herbert Rübben; Kurt Werner Schmid; Klaus J Schmitz; Alexander Schramm; Winfried Siffert; Johannes H Schulte
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.
International journal of cancer. Journal international du cancer 2011;129(10):2390-9.
2011: Zaki Shaikhibrahim; Reinhard Buettner; Jörg Ellinger; Andreas Lindstrot; Sebastian Rogenhofer; Nicolas Wernert
Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation.
International journal of molecular medicine 2011;28(5):799-807.
2011: Hans-Ulrich Schildhaus; Roland Schüle; Hiroshi Sonobe; Susanne Steiner; Shinya Tanaka; Eva Wardelmann; Reinhard Buettner; Wolfgang Hartmann; Sabine Merkelbach-Bruse; Raffael Riegel; Jutta Kirfel
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors.
Human pathology 2011;42(11):1667-75.
2011: Zaki Shaikhibrahim; Reinhard Buettner; Andreas Lindstrot; Nicolas Wernert
Analysis of laser-microdissected prostate cancer tissues reveals potential tumor markers.
International journal of molecular medicine 2011;28(4):605-11.
2011: Nicolaus Friedrichs; Reinhard Buettner; Jacqueline Czerwitzki; Elmar Endl; Akira Kawai; Dagmar Kindler; Arend Koch; Olle Larsson; Gunhild Mechtersheimer; Roland Penzel; Marcus Renner; Peter Schirmacher; Elisabeth Sievers; Susanne Steiner; Shinya Tanaka; Marcel Trautmann; Eva Wardelmann; Peter Wurst; Wolfgang Hartmann
Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma.
International journal of cancer. Journal international du cancer 2011;129(7):1564-75.
2011: Zaki Shaikhibrahim; Andreas Lindstrot; Berit Langer; Reinhard Buettner; Nicolas Wernert
Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.
International journal of molecular medicine 2011;28(1):89-93.
2011: Zaki Shaikhibrahim; Andreas Lindstrot; Berit Langer; Reinhard Buettner; Nicolas Wernert
Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.
International journal of molecular medicine 2011;27(6):811-9.
2011: Zaki Shaikhibrahim; Berit Langer; Andreas Lindstrot; Alexandra Florin; Anja Bosserhoff; Reinhard Buettner; Nicolas Wernert
Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.
Oncology reports 2011;25(4):1125-9.
2011: Katrin Hesse; Jutta Kirfel; Simone Kurt; Reinhard Buettner; Kristina Vaupel; Markus Moser
AP-2δ is a crucial transcriptional regulator of the posterior midbrain.
PloS one 2011;6(8):e23483.
2010: Soyoung Lim; Eric Metzger; Roland Schüle; Jutta Kirfel; Reinhard Buettner
Epigenetic regulation of cancer growth by histone demethylases.
International journal of cancer. Journal international du cancer 2010;127(9):1991-8.
2010: Dimitrios Pantelis; Mustapha S Kabba; Jutta Kirfel; Philip Kahl; Sven Wehner; Reinhard Buettner; Andreas Hirner; Jörg C Kalff
Transient perioperative pharmacologic inhibition of muscularis macrophages as a target for prophylaxis of postoperative ileus does not affect anastomotic healing in mice.
Surgery 2010;148(1):59-70.
2010: Uta Flucke; Maria Theresia Flucke; Ludwig Hoy; Elisabeth Breuer; Rolf Goebbels; Kerstin Rhiem; Rita Schmutzler; Helene Winzenried; Michael Braun; Susanne Steiner; Reinhard Buettner; Heidrun Gevensleben
Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach.
Histopathology 2010;56(7):852-9.
2010: Eric Metzger; Axel Imhof; Dharmeshkumar Patel; Philip Kahl; Katrin Hoffmeyer; Nicolaus Friedrichs; Judith M Müller; Holger Greschik; Jutta Kirfel; Sujuan Ji; Natalia Kunowska; Christian Beisenherz-Huss; Thomas Günther; Reinhard Buettner; Roland Schüle
Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
Nature 2010;464(7289):792-6.
2009: Wolfgang Hartmann; Jan Küchler; Arend Koch; Nicolaus Friedrichs; Andreas Waha; Elmar Endl; Jacqueline Czerwitzki; Dagmar Metzger; Susanne Steiner; Peter Wurst; Ivo Leuschner; Dietrich von Schweinitz; Reinhard Buettner; Torsten Pietsch
Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4538-45.
2009: Johannes H Schulte; Falk Pentek; Wolfgang Hartmann; Alexander Schramm; Nicolaus Friedrichs; Ingrid Øra; Jan Koster; Rogier Versteeg; Jutta Kirfel; Reinhard Buettner; Angelika Eggert
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo.
International journal of cancer. Journal international du cancer 2009;124(10):2488-94.
2009: Sebastian Zimmer; Philip Kahl; Theresa M Buhl; Susanne Steiner; Eva Wardelmann; Sabine Merkelbach-Bruse; Reinhard Buettner; Lukas Heukamp
Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling.
Journal of cancer research and clinical oncology 2009;135(5):723-30.
2009: Johannes H Schulte; Sebastian Horn; Stefanie Schlierf; Alexander Schramm; Lukas Heukamp; Holger Christiansen; Reinhard Buettner; Bernd Berwanger; Angelika Eggert
MicroRNAs in the pathogenesis of neuroblastoma.
Cancer letters 2009;274(1):10-5.
2009: Philip Kahl; Susanne Wolf; Alexander Adam; Lukas Heukamp; Jörg Ellinger; Roland Vorreuther; Gerold Solleder; Reinhard Buettner
Saturation biopsy improves preoperative Gleason scoring of prostate cancer.
Pathology, research and practice 2009;205(4):259-64.
2008: Nicolaus Friedrichs; J Küchler; Elmar Endl; Arend Koch; J Czerwitzki; P Wurst; D Metzger; J H Schulte; M I Holst; Lukas Heukamp; O Larsson; S Tanaka; A Kawai; Eva Wardelmann; Reinhard Buettner; Torsten Pietsch; Wolfgang Hartmann
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
The Journal of pathology 2008;216(4):428-39.
2008: Johannes H Schulte; Jutta Kirfel; Soyoung Lim; Alexander Schramm; Nicolaus Friedrichs; Hedwig E Deubzer; Olaf Witt; Angelika Eggert; Reinhard Buettner
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells.
Cancer letters 2008;271(1):56-63.
2008: Andreas Thalheimer; Marcus Schlemmer; Marco Bueter; Sabine Merkelbach-Bruse; Hans-Ulrich Schildhaus; Reinhard Buettner; Edgar Hartung; Arnulf Thiede; Detlef Meyer; Martin Fein; Jorn Maroske; Eva Wardelmann
Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.
The American journal of surgical pathology 2008;32(10):1560-5.
2008: Jung Park; Carola Will; Bernd Martin; Lucia Gullotti; Nicolaus Friedrichs; Reinhard Buettner; Holm Schneider; Stephan Ludwig; Viktor Wixler
Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(7):2508-20.
2008: Frank Grünhage; Matthias Jungck; Christof Lamberti; Christine Berg; Ursula Becker; Hildegard Schulte-Witte; Dominik Plassmann; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Reinhard Buettner; Tilman Sauerbruch; Frank Lammert
Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.
International journal of colorectal disease 2008;23(2):147-54.
2008: Johannes H Schulte; Sebastian Horn; Tobias Otto; Birgit Samans; Lukas Heukamp; Ursula-Christa Eilers; Michael Krause; Kathy Astrahantseff; Ludger Klein-Hitpass; Reinhard Buettner; Alexander Schramm; Holger Christiansen; Martin Eilers; Angelika Eggert; Bernd Berwanger
MYCN regulates oncogenic MicroRNAs in neuroblastoma.
International journal of cancer. Journal international du cancer 2008;122(3):699-704.
2008: Frank Grünhage; Matthias Jungck; Christof Lamberti; Hildegard Keppeler; Ursula Becker; Hildegard Schulte-Witte; Dominik Plassmann; Nicolaus Friedrichs; Reinhard Buettner; Stefan Aretz; Tilman Sauerbruch; Frank Lammert
Effects of common haplotypes of the ileal sodium dependent bile acid transporter gene on the development of sporadic and familial colorectal cancer: a case control study.
BMC medical genetics 2008;9():70.
2008: Frank Grünhage; Matthias Jungck; Christof Lamberti; Hildegard Schulte-Witte; Dominik Plassmann; Ursula Becker; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Reinhard Buettner; Tilman Sauerbruch; Frank Lammert
Contribution of common monoallelic MUTYH gene variants in German patients with familial colorectal cancer.
Cancer biomarkers : section A of Disease markers 2008;4(2):55-61.
2008: Eric Metzger; Na Yin; Melanie Wissmann; Natalia Kunowska; Kristin Fischer; Nicolaus Friedrichs; Debasis Patnaik; Jonathan M. G. Higgins; Noelle Potier; Karl-Heinz Scheidtmann; Reinhard Buettner; Roland Schüle
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.
Nature cell biology 2008;10(1):53-60.
2008: Nils Rahner; Nicolaus Friedrichs; V Steinke; Stefan Aretz; Waltraut Friedl; Reinhard Buettner; Elisabeth Mangold; Peter Propping; Constanze Walldorf
Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
The Journal of pathology 2008;214(1):10-6.
2008: Jörg Ellinger; Patrick J Bastian; Kim I Haan; Lukas Heukamp; Reinhard Buettner; Rolf Fimmers; Stefan C Mueller; Alexander von Ruecker
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.
International journal of cancer. Journal international du cancer 2008;122(1):138-43.
2007: Katharina Biermann; Lukas Heukamp; Klaus Steger; Hui Zhou; Folker E Franke; Violetta Sonnack; Ralph Brehm; Johannes Berg; Patrick J Bastian; Stefan C Muller; Lihua Wang-Eckert; Reinhard Buettner
Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Cancer genomics & proteomics 2007;4(5):359-67.
2007: Meliha Karsak; Evelyn Gaffal; Rahul Date; Lihua Wang-Eckhardt; Jennifer Rehnelt; Stefania Petrosino; Katarzyna Starowicz; Regina Steuder; Eberhard Schlicker; Benjamin F Cravatt; Urij Rampampam; Reinhard Buettner; Sabine Werner; Vincenzo Di Marzo; Thomas Tüting; Andreas Zimmer
Attenuation of allergic contact dermatitis through the endocannabinoid system.
Science (New York, N.Y.) 2007;316(5830):1494-7.
2007: Philip Kahl; Lukas Heukamp; Reinhard Buettner; Nicolaus Friedrichs; Bettina Roesing; Gisela Knopfle
Orofaciodigital syndrome type IV (Mohr-Majewski syndrome): report of a family with two affected siblings.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2007;10(3):239-43.
2007: Annette Pantelis; Dimitrios Pantelis; Petra Ruemmele; Arndt Hartmann; Ferdinand Hofstaedter; Reinhard Buettner; Friedrich Bootz; Robert Stoehr
p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Oncology reports 2007;17(5):1243-8.
2007: Viktor Wixler; Stephanie Hirner; Judith M Müller; Lucia Gullotti; Carola Will; Jutta Kirfel; Thomas Günther; Holm Schneider; Anja Bosserhoff; Hubert Schorle; Jung Park; Roland Schüle; Reinhard Buettner
Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.
The Journal of cell biology 2007;177(1):163-72.
2007: Melanie Wissmann; Na Yin; Judith M Müller; Holger Greschik; Barna D Fodor; Thomas Jenuwein; Christine Vogler; Robert Schneider; Thomas Günther; Reinhard Buettner; Eric Metzger; Roland Schüle
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Nature cell biology 2007;9(3):347-53.
2007: Nils Rahner; Nicolaus Friedrichs; Maria Wehner; Verena Steinke; Stefan Aretz; Waltraut Friedl; Reinhard Buettner; Elisabeth Mangold; Peter Propping; Constanze Walldorf
Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Acta oncologica (Stockholm, Sweden) 2007;46(6):763-9.
2007: Philip Kahl; Reinhard Buettner; Nicolaus Friedrichs; Sabine Merkelbach-Bruse; Joerg Wenzel; Lukas Carl Heukamp
Kaposi's sarcoma of the gastrointestinal tract: report of two cases and review of the literature.
Pathology, research and practice 2007;203(4):227-31.
2007: Elisabeth Mangold; Nils Rahner; Nicolaus Friedrichs; Reinhard Buettner; Constanze Pagenstecher; Stefan Aretz; Waltraut Friedl; Thomas Ruzicka; Peter Propping; Arno Rütten; Roland Kruse
MSH6 mutation in Muir-Torre syndrome: could this be a rare finding?
The British journal of dermatology 2007;156(1):158-62.
2006: Philip Kahl; Lucia Gullotti; Lukas Heukamp; Susanne Wolf; Nicolaus Friedrichs; Roland Vorreuther; Gerold Solleder; Patrick J Bastian; Jörg Ellinger; Eric Metzger; Roland Schüle; Reinhard Buettner
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Cancer research 2006;66(23):11341-7.
2006: Anja Bosserhoff; Elke-Ingrid Grussendorf-Conen; Albert Rübben; Sabine Rudnik-Schöneborn; Klaus Zerres; Reinhard Buettner; Sabine Merkelbach-Bruse
Multiple colon carcinomas in a patient with Cowden syndrome.
International journal of molecular medicine 2006;18(4):643-7.
2006: Jutta Kirfel; Jan Senderek; Markus Moser; Anke Röper; Claudia Stendel; Carsten Bergmann; Klaus Zerres; Reinhard Buettner
Cloning, expression and characterization of the murine orthologue of SBF2, the gene mutated in Charcot-Marie-Tooth disease type 4B2.
Gene expression patterns : GEP 2006;6(8):978-84.
2006: Damia Tormo; Aleix Ferrer; Evelyn Gaffal; Joerg Wenzel; Etiena Basner-Tschakarjan; Julia Steitz; Lukas Heukamp; Ines Gütgemann; Reinhard Buettner; Marcos Malumbres; Mariano Barbacid; Glenn Merlino; Thomas Tüting
Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.
The American journal of pathology 2006;169(2):665-72.
2006: Nicolaus Friedrichs; Lydia Kriegl; Christopher Poremba; Karl-Ludwig Schaefer; Helmut E Gabbert; Akihiko Shimomura; Ellen Paggen; Sabine Merkelbach-Bruse; Reinhard Buettner
Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded study.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(2):83-9.
2006: Eva Wardelmann; Sabine Merkelbach-Bruse; Katharina Pauls; Nadja Thomas; Hans-Ulrich Schildhaus; Thomas Heinicke; Nicola Speidel; Torsten Pietsch; Reinhard Buettner; Daniel Pink; Peter Reichardt; Peter Hohenberger
Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1743-9.
2006: Constanze Pagenstecher; Maria Wehner; Waltraut Friedl; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Marlies Sengteller; Wolfram Henn; Reinhard Buettner; Peter Propping; Elisabeth Mangold
Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
Human genetics 2006;119(1-2):9-22.
2006: Christoph Engel; Jochen Forberg; Elke Holinski-Feder; Constanze Pagenstecher; Jens Plaschke; Matthias Kloor; Christopher Poremba; Christian Pox; Josef Rüschoff; Gisela Keller; Wolfgang Dietmaier; Petra Rümmele; Nicolaus Friedrichs; Elisabeth Mangold; Reinhard Buettner; Hans K Schackert; Peter Kienle; Susanne Stemmler; Gabriela Moeslein; Markus Loeffler
Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer.
International journal of cancer. Journal international du cancer 2006;118(1):115-22.
2005: Elisabeth Mangold; Constanze Pagenstecher; Waltraut Friedl; Hans-Peter Fischer; Sabine Merkelbach-Bruse; Maike Ohlendorf; Nicolaus Friedrichs; Stefan Aretz; Reinhard Buettner; Peter Propping; Micaela Mathiak
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
The Journal of pathology 2005;207(4):385-95.
2005: Nicolaus Friedrichs; Maria Adele Testi; Luisa Moiraghi; Piergiorgio Modena; Ellen Paggen; Andreas Plötner; Volker Wiechmann; Luisa Mantovani-Löffler; Sabine Merkelbach-Bruse; Reinhard Buettner; Eva Wardelmann
Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entity.
International journal of surgical pathology 2005;13(4):313-8.
2005: Elisabeth Mangold; Constanze Pagenstecher; Waltraut Friedl; Micaela Mathiak; Reinhard Buettner; Christoph Engel; Markus Loeffler; Elke Holinski-Feder; Yvonne Müller-Koch; Gisela Keller; Hans K Schackert; Stefan Krüger; Timm Goecke; Gabriela Moeslein; Matthias Kloor; Johannes Gebert; Erdmute Kunstmann; Karsten Schulmann; Josef Rüschoff; Peter Propping
Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
International journal of cancer. Journal international du cancer 2005;116(5):692-702.
2005: Eric Metzger; Melanie Wissmann; Na Yin; Judith M Müller; Robert Schneider; Antoine H F M Peters; Thomas Günther; Reinhard Buettner; Roland Schüle
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
Nature 2005;437(7057):436-9.
2005: Karin Hartmann; Eva Wardelmann; Yongsheng Ma; Sabine Merkelbach-Bruse; Liane M Preussner; Carla Woolery; Stephan E Baldus; Thomas Heinicke; Juergen Thiele; Reinhard Buettner; B Jack Longley
Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.
Gastroenterology 2005;129(3):1042-6.
2005: Markus Moser; Sonja Matthiesen; Jutta Kirfel; Hubert Schorle; Carsten Bergmann; Jan Senderek; Sabine Rudnik-Schöneborn; Klaus Zerres; Reinhard Buettner
A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD).
Hepatology (Baltimore, Md.) 2005;41(5):1113-21.
2005: Stefan M Woerner; Matthias Kloor; Annegret Mueller; Josef Rueschoff; Nicolaus Friedrichs; Reinhard Buettner; Moriz Buzello; Peter Kienle; Hanns-Peter Knaebel; Erdmute Kunstmann; Constanze Pagenstecher; Hans K Schackert; Gabriela Möslein; Holger Vogelsang; Magnus von Knebel Doeberitz; Johannes Gebert
Microsatellite instability of selective target genes in HNPCC-associated colon adenomas.
Oncogene 2005;24(15):2525-35.
2005: Nicolaus Friedrichs; richard jäger; Ellen Paggen; Christian Rudlowski; Sabine Merkelbach-Bruse; Hubert Schorle; Reinhard Buettner
Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(3):431-8.
2004: Annegret Müller; Giuseppe Giuffre; Tina Bocker Edmonston; Micaela Mathiak; Beate Roggendorf; Ernst Heinmöller; Thomas Brodegger; Giovanni Tuccari; Elisabeth Mangold; Reinhard Buettner; Josef Rüschoff
Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry.
The Journal of molecular diagnostics : JMD 2004;6(4):308-15.
2004: Klaus Zerres; Jan Senderek; Sabine Rudnik-Schöneborn; Thomas Eggermann; J Kunze; T Mononen; H Kääriäinen; Jutta Kirfel; Markus Moser; Reinhard Buettner; Carsten Bergmann
New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene.
Clinical genetics 2004;66(1):53-7.
2004: Anja Bosserhoff; Markus Moser; Reinhard Buettner
Characterization and expression pattern of the novel MIA homolog TANGO.
Gene expression patterns : GEP 2004;4(4):473-9.
2004: Markus Moser; Yong Li; Kristina Vaupel; Doris Kretzschmar; Reinhart Kluge; Paul Glynn; Reinhard Buettner
Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice.
Molecular and cellular biology 2004;24(4):1667-79.
2003: Sabine Merkelbach-Bruse; Eva Wardelmann; Peter Behrens; Inge Losen; Reinhard Buettner; Nicolaus Friedrichs
Current diagnostic methods of HER-2/neu detection in breast cancer with special regard to real-time PCR.
The American journal of surgical pathology 2003;27(12):1565-70.
2003: Anja Bosserhoff; Raphael Stoll; Jonathan P Sleeman; Frauke Bataille; Reinhard Buettner; Tad A Holak
Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.
Laboratory investigation; a journal of technical methods and pathology 2003;83(11):1583-94.
2003: Monica Arias; Sibille Sauer-Lehnen; Jens Treptau; Nora Janoschek; Ingo Theuerkauf; Reinhard Buettner; Axel M Gressner; Ralf Weiskirchen
Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
BMC gastroenterology 2003;3():29.
2003: Iris Behrmann; Susanne Wallner; Waraporn Komyod; Peter C Heinrich; Marion M Schuierer; Reinhard Buettner; Anja Bosserhoff
Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
The American journal of pathology 2003;163(2):683-90.
2003: Nicolaus Friedrichs; Roland Vorreuther; Hans-Peter Fischer; Otmar D Wiestler; Reinhard Buettner
Neurocytoma arising in the pelvis.
Virchows Archiv : an international journal of pathology 2003;443(2):217-9.
2003: Anja Bosserhoff; Reinhard Buettner
Establishing the protein MIA (melanoma inhibitory activity) as a marker for chondrocyte differentiation.
Biomaterials 2003;24(19):3229-34.
2003: Erhard Bierhoff; Kirsten Appel; Thorsten Appel; Reinhard Buettner; Eva Wardelmann
Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
Anticancer research 2003;23(3B):2697-700.
2003: Anja Bosserhoff; Markus Moser; Juergen Schölmerich; Reinhard Buettner; Claus Hellerbrand
Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.
The Journal of biological chemistry 2003;278(17):15225-31.
2003: Markus Moser; Sandra Dahmen; Reinhart Kluge; Hermann Gröne; Judith Dahmen; Dagmar Kunz; Hubert Schorle; Reinhard Buettner
Terminal renal failure in mice lacking transcription factor AP-2 beta.
Laboratory investigation; a journal of technical methods and pathology 2003;83(4):571-8.
2003: Ina Poser; Michaela Golob; Reinhard Buettner; Anja Bosserhoff
Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.
Molecular and cellular biology 2003;23(8):2991-8.
2003: Eric Metzger; Judith M Müller; Stefano Ferrari; Reinhard Buettner; Roland Schüle
A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer.
The EMBO journal 2003;22(2):270-80.
2003: Nicolaus Friedrichs; Anna-Maria Eis-Hubinger; Albert Heim; Eva Platen; Hui Zhou; Reinhard Buettner
Acute adenoviral infection of a graft by serotype 35 following renal transplantation.
Pathology, research and practice 2003;199(8):565-70.
2002: Ina Poser; Michaela Golob; Michael Weidner; Reinhard Buettner; Anja Bosserhoff
Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Cancer research 2002;62(20):5962-6.
2002: Markus Moser; Anja Bosserhoff; Ernst B Hunziker; Linda Sandell; Reinhard Fässler; Reinhard Buettner
Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.
Molecular and cellular biology 2002;22(5):1438-45.
2002: Judith M Müller; Eric Metzger; Holger Greschik; Anja Bosserhoff; Luka Mercep; Reinhard Buettner; Roland Schüle
The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus.
The EMBO journal 2002;21(4):736-48.
2002: Nicolaus Friedrichs; Roland Vorreuther; Christopher Poremba; Karl-Ludwig Schafer; Alfred Böcking; Reinhard Buettner; Hui Zhou
Primitive neuroectodermal tumor (PNET) in the differential diagnosis of malignant kidney tumors.
Pathology, research and practice 2002;198(8):563-9.
2002: Rafael Dobrowolski; Rüdiger Hein; Reinhard Buettner; Anja Bosserhoff
Loss of p14ARF expression in melanoma.
Archives of dermatological research 2002;293(11):545-51.
2001: Anja Bosserhoff; B Echtenacher; R Hein; Reinhard Buettner
Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
Melanoma research 2001;11(4):417-21.
2001: Marion M Schuierer; K Hilger-Eversheim; Thomas Dobner; Anja Bosserhoff; Markus Moser; J Turner; M Crossley; Reinhard Buettner
Induction of AP-2alpha expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1.
The Journal of biological chemistry 2001;276(30):27944-9.
2001: Ina Poser; David Domínguez; Antonio García De Herreros; A Varnai; Reinhard Buettner; Anja Bosserhoff
Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.
The Journal of biological chemistry 2001;276(27):24661-6.
2001: A Gütgemann; Michaela Golob; S Müller; Reinhard Buettner; Anja Bosserhoff
Isolation of invasion-associated cDNAs in melanoma.
Archives of dermatological research 2001;293(6):283-90.
2001: K Günther; A Fleischer; Reinhard Buettner; Anja Bosserhoff
Detection of invasion-related chromosomal changes in highly and weakly invasive melanoma cell clones by a modified comparative genomic hybridization approach.
Melanoma research 2001;11(2):105-15.
2001: Benita Hermanns; Anna Brunn; Ernst R Schwarz; Jörg S Sachweh; Ingrid M Seipelt; J Michael Schröder; U Vogel; Friedrich A Schoendube; Reinhard Buettner
Fulminant toxoplasmosis in a heart transplant recipient.
Pathology, research and practice 2001;197(3):211-5.
2001: A Juergensen; U Holzapfel; R Hein; W Stolz; Reinhard Buettner; Anja Bosserhoff
Comparison of two prognostic markers for malignant melanoma: MIA and S100 beta.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(1):54-8.
2000: Kristina Hilger-Eversheim; Markus Moser; Hubert Schorle; Reinhard Buettner
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control.
Gene 2000;260(1-2):1-12.
2000: Sabine Merkelbach-Bruse; S Köse; Inge Losen; Anja Bosserhoff; Reinhard Buettner
High throughput genetic screening for the detection of hereditary non-polyposis colon cancer (HNPCC) using capillary electrophoresis.
Combinatorial chemistry & high throughput screening 2000;3(6):519-24.
2000: Anja Bosserhoff; Reinhard Buettner; C Hellerbrand
Use of capillary electrophoresis for high throughput screening in biomedical applications. A minireview.
Combinatorial chemistry & high throughput screening 2000;3(6):455-66.
2000: Markus Guba; Anja Bosserhoff; Markus Steinbauer; Christoph Abels; Matthias Anthuber; Reinhard Buettner; K W Jauch
Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
British journal of cancer 2000;83(9):1216-22.
2000: Michaela Golob; Reinhard Buettner; Anja Bosserhoff
Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma.
The Journal of investigative dermatology 2000;115(1):42-7.
2000: C Roth; Marion M Schuierer; K Günther; Reinhard Buettner
Genomic structure and DNA binding properties of the human zinc finger transcriptional repressor AP-2rep (KLF12).
Genomics 2000;63(3):384-90.
2000: Judith M Müller; U Isele; Eric Metzger; A Rempel; M Moser; A Pscherer; T Breyer; Christian J F Holubarsch; Reinhard Buettner; Roland Schüle
FHL2, a novel tissue-specific coactivator of the androgen receptor.
The EMBO journal 2000;19(3):359-69.
1999: Anja Bosserhoff; M Lederer; M Kaufmann; R Hein; W Stolz; Rainer Apfel; Ulrich Bogdahn; Reinhard Buettner
MIA, a novel serum marker for progression of malignant melanoma.
Anticancer research 1999;19(4A):2691-3.
1999: Marcus Mühlbauer; N Langenbach; Wilhelm Stolz; R Hein; Michael Landthaler; Reinhard Buettner; Anja Bosserhoff
Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1099-105.
1999: U Dörflinger; A Pscherer; Markus Moser; P Rümmele; Roland Schüle; Reinhard Buettner
Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain.
Molecular and cellular biology 1999;19(5):3736-47.
1999: Anja Bosserhoff; M Moser; R Hein; Michael Landthaler; Reinhard Buettner
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
The Journal of pathology 1999;187(4):446-54.
1999: A Glaessl; Anja Bosserhoff; Reinhard Buettner; Ulrich Hohenleutner; Michael Landthaler; Wilhelm Stolz
Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Archives of dermatological research 1999;291(2-3):81-7.
1999: Axel imhof; Marion M Schuierer; O Werner; Markus Moser; C Roth; R Bauer; Reinhard Buettner
Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor.
Molecular and cellular biology 1999;19(1):194-204.
1998: MM Kroiss; Anja Bosserhoff; Thomas Vogt; Reinhard Buettner; Thomas Bogenrieder; Michael Landthaler; Wilhelm Stolz
Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas.
Melanoma research 1998;8(6):504-9.
1998: K Jacob; F Wach; U Holzapfel; R Hein; E Lengyel; Reinhard Buettner; Anja Bosserhoff
In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.
Melanoma research 1998;8(3):211-9.
1997: Markus Moser; A Pscherer; C Roth; J Becker; G Mücher; Klaus Zerres; C Dixkens; J Weis; Lisa M Guay-Woodford; Reinhard Buettner; Reinhard Fässler
Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.
Genes & development 1997;11(15):1938-48.
1997: Anja Bosserhoff; M Kaufmann; B Kaluza; I Bartke; H Zirngibl; R Hein; W Stolz; Reinhard Buettner
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.
Cancer research 1997;57(15):3149-53.
1997: R Dammer; J Stavenow; P Held; J Schröder; Herbert Niederdellmann; F Hofstädter; Reinhard Buettner
Pigmented peripheral nerve sheath tumor of the oral cavity with expression of AP-2 beta and c-RET: a case report.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1997;84(1):40-4.
1997: Markus Moser; J Rüschoff; Reinhard Buettner
Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis.
Developmental dynamics : an official publication of the American Association of Anatomists 1997;208(1):115-24.
1996: A Pscherer; U Dörflinger; Jutta Kirfel; K Gawlas; J Rüschoff; Reinhard Buettner; Roland Schüle
The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene.
The EMBO journal 1996;15(23):6680-90.
1996: MR Koehler; Anja Bosserhoff; G von Beust; A Bauer; Armin Blesch; Reinhard Buettner; Jürgen Schlegel; Ulrich Bogdahn; Michael Schmid
Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH).
Genomics 1996;35(1):265-7.
1996: Reinhard Buettner; P Schleicher; B Schleicher; J Rüschoff; F Hofstädter
[Benign placental trophoblast nodule. Case report with overview of proliferative diseases of the intermediate stage trophoblast].
Geburtshilfe und Frauenheilkunde 1996;56(5):257-61.
1996: Anja Bosserhoff; R Hein; Ulrich Bogdahn; Reinhard Buettner
Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA.
The Journal of biological chemistry 1996;271(1):490-5.
1995: Markus Moser; Axel imhof; A Pscherer; R Bauer; W Amselgruber; F Sinowatz; F Hofstädter; Roland Schüle; Reinhard Buettner
Cloning and characterization of a second AP-2 transcription factor: AP-2 beta.
Development (Cambridge, England) 1995;121(9):2779-88.
1995: S Gaubatz; Axel imhof; R Dosch; O Werner; P Mitchell; Reinhard Buettner; Martin Eilers
Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
The EMBO journal 1995;14(7):1508-19.
1995: T Bocker; A Bittinger; Wolf F Wieland; Reinhard Buettner; G Fauser; Ferdinand Hofstaedter; J Rüschoff
In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(3):226-31.
1995: K Jacob; Anja Bosserhoff; F Wach; Ruth Knüchel; E C Klein; R Hein; Reinhard Buettner
Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones.
International journal of cancer. Journal international du cancer 1995;60(5):668-75.
1994: Armin Blesch; Anja Bosserhoff; R Apfel; Christian Behl; B Hessdoerfer; A Schmitt; P Jachimczak; F Lottspeich; Reinhard Buettner; Ulrich Bogdahn
Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA.
Cancer research 1994;54(21):5695-701.
1994: Perry Kannan; Reinhard Buettner; Paul J Chiao; S O Yim; Mona Sarkiss; Michael A Tainsky
N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation.
Genes & development 1994;8(11):1258-69.
1994: R Bauer; Axel imhof; A Pscherer; H Kopp; Markus Moser; S Seegers; M Kerscher; Michael A Tainsky; Ferdinand Hofstaedter; Reinhard Buettner
The genomic structure of the human AP-2 transcription factor.
Nucleic acids research 1994;22(8):1413-20.
1994: R Dermietzel; T K Hwang; Reinhard Buettner; A Hofer; E Dotzler; M Kremer; R Deutzmann; F P Thinnes; G I Fishman; david spray
Cloning and in situ localization of a brain-derived porin that constitutes a large-conductance anion channel in astrocytic plasma membranes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(2):499-503.
1994: Reinhard Buettner; Markus Moser; A Pscherer; Axel imhof; R Bauer; Ferdinand Hofstaedter
[Molecular cloning of a new AP-2 transcription factor, AP-2beta, and its function in cell differentiation].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1994;78():38-42.
1993: Markus Moser; A Pscherer; R Bauer; Axel imhof; S Seegers; M Kerscher; Reinhard Buettner
The complete murine cDNA sequence of the transcription factor AP-2.
Nucleic acids research 1993;21(20):4844.
1993: Reinhard Buettner; Perry Kannan; Axel imhof; R Bauer; S O Yim; R Glockshuber; Michael W Van Dyke; Michael A Tainsky
An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2.
Molecular and cellular biology 1993;13(7):4174-85.
1993: L Rohrer; Friedrich Raulf; Christian Bruns; Reinhard Buettner; Ferdinand Hofstaedter; Roland Schüle
Cloning and characterization of a fourth human somatostatin receptor.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(9):4196-200.
1993: S Meyer; Reinhard Buettner; P Sauer; Leopold Rupprecht
[Acute arterial occlusion of the upper extremity by tumor embolism].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1993;64(5):424-6.
1993: Reinhard Buettner; R Bauer; Axel imhof; Michael A Tainsky; Ferdinand Hofstaedter
[AP-2: a nuclear effector of malignant transformation by ras oncogene].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1993;77():271-5.
1993: H Kopp; J R Masters; Wolf F Wieland; Ferdinand Hofstaedter; Reinhard Buettner
[Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1993;77():129-32.
1993: J Rüschoff; T Bocker; Reinhard Buettner; A Bittinger; Wolf F Wieland; Ferdinand Hofstaedter
[In vivo and ex vivo expression of nucleolar proliferation-associated antigens (p120, B23) in the prostate].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1993;77():103-6.
1992: K Le-Ruppert; J R Masters; Ruth Knuechel; S Seegers; Michael A Tainsky; Ferdinand Hofstaedter; Reinhard Buettner
The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene.
International journal of cancer. Journal international du cancer 1992;51(4):646-51.
1991: Perry Kannan; Reinhard Buettner; D R Pratt; Michael A Tainsky
Identification of a retinoic acid-inducible endogenous retroviral transcript in the human teratocarcinoma-derived cell line PA-1.
Journal of virology 1991;65(11):6343-8.
1991: Michael A Tainsky; S O Yim; D B Krizman; Perry Kannan; Paul J Chiao; Tapas Mukhopadhyay; Reinhard Buettner
Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Oncogene 1991;6(9):1575-82.
1991: Reinhard Buettner; S O Yim; Y S Hong; E Boncinelli; Michael A Tainsky
Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells.
Molecular and cellular biology 1991;11(7):3573-83.